ID   PDE3B_RAT               Reviewed;        1108 AA.
AC   Q63085;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   24-JUL-2024, entry version 142.
DE   RecName: Full=cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B {ECO:0000305|PubMed:9631240};
DE            EC=3.1.4.17 {ECO:0000269|PubMed:9631240};
DE   AltName: Full=CGI PDE;
DE   AltName: Full=Cyclic GMP-inhibited phosphodiesterase B;
DE            Short=CGI-PDE B;
DE   AltName: Full=RcGIPl {ECO:0000303|PubMed:8395509};
GN   Name=Pde3b {ECO:0000312|RGD:61943};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Adipose tissue;
RX   PubMed=8395509; DOI=10.1016/s0021-9258(17)46666-x;
RA   Taira M., Hockman S.C., Calvo J.C., Taira M., Belfrage P.,
RA   Manganiello V.C.;
RT   "Molecular cloning of the rat adipocyte hormone-sensitive cyclic GMP-
RT   inhibited cyclic nucleotide phosphodiesterase.";
RL   J. Biol. Chem. 268:18573-18579(1993).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, AND ACTIVITY REGULATION.
RC   TISSUE=Adipose tissue;
RX   PubMed=9631240; DOI=10.1007/bf02737830;
RA   He R., Komas N., Ekholm D., Murata T., Taira M., Hockman S.C., Degerman E.,
RA   Manganiello V.C.;
RT   "Expression and characterization of deletion recombinants of two cGMP-
RT   inhibited cyclic nucleotide phosphodiesterases (PDE-3).";
RL   Cell Biochem. Biophys. 29:89-111(1998).
CC   -!- FUNCTION: Cyclic nucleotide phosphodiesterase with a dual-specificity
CC       for the second messengers cAMP and cGMP, which are key regulators of
CC       many important physiological processes (PubMed:9631240). Regulates
CC       angiogenesis by inhibiting the cAMP-dependent guanine nucleotide
CC       exchange factor RAPGEF3 and downstream phosphatidylinositol 3-kinase
CC       gamma-mediated signaling (By similarity). Controls cardiac
CC       contractility by reducing cAMP concentration in cardiocytes (By
CC       similarity). {ECO:0000250|UniProtKB:Q13370,
CC       ECO:0000250|UniProtKB:Q61409, ECO:0000269|PubMed:9631240}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a nucleoside 3',5'-cyclic phosphate + H2O = a nucleoside 5'-
CC         phosphate + H(+); Xref=Rhea:RHEA:14653, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57867, ChEBI:CHEBI:58464; EC=3.1.4.17;
CC         Evidence={ECO:0000269|PubMed:9631240};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:14654;
CC         Evidence={ECO:0000305|PubMed:9631240};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3',5'-cyclic AMP + H2O = AMP + H(+); Xref=Rhea:RHEA:25277,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:58165,
CC         ChEBI:CHEBI:456215; Evidence={ECO:0000269|PubMed:9631240};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:25278;
CC         Evidence={ECO:0000305|PubMed:9631240};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3',5'-cyclic GMP + H2O = GMP + H(+); Xref=Rhea:RHEA:16957,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:57746,
CC         ChEBI:CHEBI:58115; Evidence={ECO:0000269|PubMed:9631240};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16958;
CC         Evidence={ECO:0000305|PubMed:9631240};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q13370};
CC       Note=Binds 2 divalent metal cations per subunit.
CC       {ECO:0000250|UniProtKB:Q13370};
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000250|UniProtKB:Q14432};
CC       Note=Binds 2 divalent metal cations per subunit.
CC       {ECO:0000250|UniProtKB:Q14432};
CC   -!- ACTIVITY REGULATION: Inhibited by cGMP. {ECO:0000269|PubMed:9631240}.
CC   -!- SUBUNIT: Homodimer (By similarity). Interacts with PIK3CG; regulates
CC       PDE3B activity and thereby cAMP levels in cells (By similarity).
CC       Interacts with RAPGEF3 and PIK3R6; form a signaling complex that
CC       regulates phosphatidylinositol 3-kinase gamma in angiogenesis (By
CC       similarity). Interacts with ABHD15; this interaction regulates PDE3B's
CC       stability and expression and, thereby, impacts the antilipolytic action
CC       of insulin (By similarity). {ECO:0000250|UniProtKB:Q13370,
CC       ECO:0000250|UniProtKB:Q61409}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:Q61409}; Multi-
CC       pass membrane protein {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Abundant in adipose tissues.
CC       {ECO:0000269|PubMed:8395509}.
CC   -!- PTM: Phosphorylation at Ser-279 mediates insulin-induced activation of
CC       PDE3B. {ECO:0000250|UniProtKB:Q61409}.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterase family.
CC       PDE3 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z22867; CAA80489.1; -; mRNA.
DR   PIR; A48508; A48508.
DR   RefSeq; NP_058925.1; NM_017229.1.
DR   AlphaFoldDB; Q63085; -.
DR   SMR; Q63085; -.
DR   STRING; 10116.ENSRNOP00000015498; -.
DR   iPTMnet; Q63085; -.
DR   PhosphoSitePlus; Q63085; -.
DR   PaxDb; 10116-ENSRNOP00000015498; -.
DR   DNASU; 29516; -.
DR   GeneID; 29516; -.
DR   KEGG; rno:29516; -.
DR   UCSC; RGD:61943; rat.
DR   AGR; RGD:61943; -.
DR   CTD; 5140; -.
DR   RGD; 61943; Pde3b.
DR   eggNOG; ENOG502QSV8; Eukaryota.
DR   InParanoid; Q63085; -.
DR   OrthoDB; 5479253at2759; -.
DR   PhylomeDB; Q63085; -.
DR   Reactome; R-RNO-165160; PDE3B signalling.
DR   Reactome; R-RNO-418555; G alpha (s) signalling events.
DR   SABIO-RK; Q63085; -.
DR   PRO; PR:Q63085; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:RGD.
DR   GO; GO:0032045; C:guanyl-nucleotide exchange factor complex; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0004115; F:3',5'-cyclic-AMP phosphodiesterase activity; IDA:UniProtKB.
DR   GO; GO:0047555; F:3',5'-cyclic-GMP phosphodiesterase activity; IDA:UniProtKB.
DR   GO; GO:0004114; F:3',5'-cyclic-nucleotide phosphodiesterase activity; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0051219; F:phosphoprotein binding; IDA:RGD.
DR   GO; GO:0043422; F:protein kinase B binding; ISS:BHF-UCL.
DR   GO; GO:0001525; P:angiogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0019933; P:cAMP-mediated signaling; IBA:GO_Central.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; ISS:BHF-UCL.
DR   GO; GO:0031018; P:endocrine pancreas development; ISO:RGD.
DR   GO; GO:0042593; P:glucose homeostasis; ISO:RGD.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; ISS:UniProtKB.
DR   GO; GO:0043951; P:negative regulation of cAMP-mediated signaling; IMP:RGD.
DR   GO; GO:0007162; P:negative regulation of cell adhesion; ISO:RGD.
DR   GO; GO:0061179; P:negative regulation of insulin secretion involved in cellular response to glucose stimulus; IMP:RGD.
DR   GO; GO:0050995; P:negative regulation of lipid catabolic process; ISO:RGD.
DR   GO; GO:0050796; P:regulation of insulin secretion; ISO:RGD.
DR   CDD; cd00077; HDc; 1.
DR   Gene3D; 1.10.1300.10; 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain; 1.
DR   InterPro; IPR003607; HD/PDEase_dom.
DR   InterPro; IPR002073; PDEase_catalytic_dom.
DR   InterPro; IPR036971; PDEase_catalytic_dom_sf.
DR   InterPro; IPR023174; PDEase_CS.
DR   PANTHER; PTHR11347; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; 1.
DR   PANTHER; PTHR11347:SF29; PHOSPHODIESTERASE; 1.
DR   Pfam; PF00233; PDEase_I; 1.
DR   SMART; SM00471; HDc; 1.
DR   SUPFAM; SSF109604; HD-domain/PDEase-like; 1.
DR   PROSITE; PS00126; PDEASE_I_1; 1.
DR   PROSITE; PS51845; PDEASE_I_2; 1.
PE   1: Evidence at protein level;
KW   Angiogenesis; cAMP; cGMP; Hydrolase; Magnesium; Membrane; Metal-binding;
KW   Phosphoprotein; Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN           1..1108
FT                   /note="cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B"
FT                   /id="PRO_0000198804"
FT   TRANSMEM        73..93
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        114..134
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        144..164
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        175..195
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        204..224
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        231..251
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          633..1070
FT                   /note="PDEase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01192"
FT   REGION          1..32
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1..32
FT                   /note="Interaction with RAPGEF3"
FT                   /evidence="ECO:0000250|UniProtKB:Q13370"
FT   REGION          405..448
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          421..445
FT                   /note="Interaction with PIK3R6"
FT                   /evidence="ECO:0000250|UniProtKB:Q13370"
FT   REGION          999..1042
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        13..27
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        415..434
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        999..1032
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        719
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:O76083"
FT   BINDING         719
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000250|UniProtKB:Q14432"
FT   BINDING         723
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q13370"
FT   BINDING         803
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q13370"
FT   BINDING         804
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000250|UniProtKB:Q14432"
FT   BINDING         804
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q13370"
FT   BINDING         804
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q13370"
FT   BINDING         919
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000250|UniProtKB:Q14432"
FT   BINDING         919
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q13370"
FT   BINDING         970
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000250|UniProtKB:Q14432"
FT   MOD_RES         15
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61409"
FT   MOD_RES         279
FT                   /note="Phosphoserine; by PKB/AKT1 or PKB/AKT2"
FT                   /evidence="ECO:0000250|UniProtKB:Q61409"
FT   MOD_RES         280
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61409"
FT   MOD_RES         427
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13370"
SQ   SEQUENCE   1108 AA;  123107 MW;  C9B5078C7D3ADD6D CRC64;
     MRKDERERDT PAMRSPPPPP PPATATAASP PESLRNGYVK SCVSPLRQDP PRSFFFHLCR
     FCNVEPPAAS LRAGARLSLA ALAAFVLAAL LGAGPERWAA AATGLRTLLS ACSLSLSPLF
     SIACAFFFLT CFLTRAQRGP DRGAGSWWLL ALPACCYLGD FAAWQWWSWL RGEPAAAAAG
     RLCLVLSCVG LLTLAPRVRL RHGVLVLLFA GLVWWVSFSG LGALPPALRP LLSCLVGGAG
     CLLALGLDHF FHVRGASPPP RSASTADEKV PVIRPRRRSS CVSLGESAAG YYGSGKMFRR
     PSLPCISREQ MILWDWDLKQ WCKPHYQNSG GGNGVDLSVL NEARNMVSDL LIDPSLPPQV
     ISSLRSISSL MGAFSGSCRP KINSFTPFPG FYPCSEVEDP VEKGDRKLHK GLSSKPSFPT
     AQLRRSSGAS GLLTSEHHSR WDRSGGKRPY QELSVSSHGC HLNGPFSSNL MTIPKQRSSS
     VSLTHHAGLR RAGALPSPSL LNSSSHVPVS AGCLTNRSPV GFLDTSDFLT KPSVTLHRSL
     GSVSSAADFH QYLRNSDSSL CSSCGHQILK YVSTCEPDGT DHHNEKSGEE DSTVFSKERL
     NIVETQEEET VKEDCRELFL EGDDHLMEEA QQPNIDQEVL LDPMLVEDYD SLIEKMSNWN
     FQIFELVEKM GEKSGRILSQ VMYTLFQDTG LLETFKIPTQ EFMNYFRALE NGYRDIPYHN
     RVHATDVLHA VWYLTTRPIP GLQQLHNNHE TETKADSDAR LSSGQIAYLS SKSCCIPDKS
     YGCLSSNIPA LELMALYVAA AMHDYDHPGR TNAFLVATNA PQAVLYNDRS VLENHHAASA
     WNLYLSRPEY NFLLNLDHME FKRFRFLVIE AILATDLKKH FDFLAEFNAK ANDVNSNGIE
     WSSENDRLLV CQVCIKLADI NGPAKDRDLH LRWTEGIVNE FYEQGDEEAT LGLPISPFMD
     RSSPQLAKLQ ESFITHIVGP LCNSYDAAGL LPGQWIEAEE GDDTESDDDD DDDDDDDDDD
     DEELDSDDEE TEDNLNPKPQ RRKGRRRIFC QLMHHLTENH KIWKEIIEEE EKCKAEGNKL
     QVDNASLPQA DEIQVIEEAD EEEEQMFE
//
